AMyC
Dedicated to Research that Advances Myeloma Treatment

The Aptium Oncology Myeloma Consortium (AMyC) is an innovative research model that has brought together an expert team of institutions and investigators to design and rapidly complete clinical trials in myeloma with the ultimate goal of identifying new drugs to treat this disease.